ÂÜÀòÂÒÂ×

Klaus-Dieter Langner is an advisor at lino Biotech. Klaus-Dieter was previously a member of the Corporate Executive Board at Grünenthal Group from July 2013 to June 2018. Prior to that, they were the Executive Vice President Grünenthal Innovation from January 2010 to December 2013. Klaus-Dieter has also held the positions of Senior Vice President Preclinical Research & Development and Vice President Preclinical Development at Grünenthal Group, as well as Head of Corporate Office and Assistant of Head of Strategic Business Unit Therapeutics at Behringwerke AG.

Klaus-Dieter Langner received their Doctor of Philosophy in Molekularbiologie from Universität zu Köln.